Patent Assignment
Reel/Frame 060227/0421
Assignment of Assignor's Interest
Recorded: 2022-06-16
Pages: 17
Assignors
O'HEAR, CAROL ELAINE
Executed: 2022-04-18
OKI, YASUHIRO
Executed: 2022-04-18
TO, IRIS TRANTHUYNGAN
Executed: 2022-04-07
Assignee
GENENTECH, INC.
1 DNA WAY, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-4990
Covered Properties
(2)
Methods for Treatment of CD20-Positive Proliferative Disorder with Mosunetuzumab and Polatuzumab Vedotin
Application:
63/292,887 →
Methods for Treatment of CD20-Positive Proliferative Disorder with Mosunetuzumab and Polatuzumab Vedotin
Patent:
12,291,575 →
Application:
17/744,262 →
Publication:
US 2022/0411528
PCT:
PCT/US2022/029226 ↗